Verification of Inactivation Methods for Removal of Biological Materials from a Biosafety Level 3 Select Agent Facility

Blow J. A. & Dohm D. J. (2004). Virus inactivation by nucleic acid extraction reagents. Journal of Virological Methods, 119, 195–198.

Code of Federal Regulations (CFR). (2008a). Title 42—Public Health; Part 73: Select agents and toxins. Washington, DC: Department of Health and Human Services. Final.

Code of Federal Regulations (CFR). (2008b). Title 7—Animals and Animal Products, Part 331: Possession, use, and transfer of biological agents and toxins. Washington, DC: Department of Agriculture. Final.

Code of Federal Regulations (CFR). (2008c). Title 9—Animals and Animal Products; Part 121: Possession, use, and transfer of select agents and toxins. Washington, DC: Department of Agriculture. Final.

Division of Select Agents and Toxins. (2010). Select agents and toxins: Theft, loss or release information document. Updated June 8, 2010. Available at: www.selectagents.gov/resources/CompleteTHEFT%20LOSS%20%20RELEASE%20guidance%20document%20June82010_FINAL.pdf. Accessed online 2012.

Division of Select Agents and Toxins. (2011). Guidance for the inactivation of select agents and toxins and rendering samples free of select agents and toxins. First published December 14, 2011. Available at: www.selectagents.gov/Guidance_for_the_Inactivation_of_Select_Agents_and_Toxins.html. Accessed online 2012.

Elliott L. H. & McCormick J. B. (1982). Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. Journal of Clinical Microbiology, 16, 704–708.

Favero M. S. & Arduino M. J. (2006). Decontamination and disinfection. In Fleming D. O. & Hunt D. L. (eds.), Biological safety: Principles and practices (pp. 373–381). Washington, DC: ASM Press.

Harding A. L. & Byers K. B. (2006). Epidemiology of laboratory-associated infections. In Fleming D. O. & Hunt D. L. (eds.), Biological safety: Principles and practices (pp. 53–80). Washington, DC: ASM Press.

Hartman A. L. & Homes L. C. (2010). Evolution of a facility-specific BSL-3 training program for the University of Pittsburgh Regional Biocontainment Laboratory. Applied Biosafety: Journal of the American Biological Safety Association, 15(3), 137–141.

Hersberger M. & Nusbaumer C. (2004). Influence of practicable virus inactivation procedures on tests for frequently measured analytes in plasma. Clinical Chemistry, 50, 944–946.

Mahanty S. & Kalway R. (1999). Cytokine measurement in biological samples after physicochemical treatment for inactivation of biosafety level 4 viral agents. Journal of Medical Virology, 59, 341–345.

Mitchell S. W. & McCormick J. B. (1984). Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. Journal of Clinical Microbiology, 20, 486–489.